Burcon NutraScience (TSX: BU), a global technology leader in plant-based protein innovation, announced that a study conducted ...

Concerto Biosciences®, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, today announced positive topline results from its first-in-human Phase 1b ...

Australia's first genetically modified banana has been tweaked to protect it from a disease that's on the verge of wiping out ...

Health and Human Services Secretary Robert F. Kennedy Jr. and his actress wife Cheryl Hines are being applauded online after the pair was spotted flying in economy class on a commercial flight. The ...

Iowa State University researchers have unlocked new secrets within the bacteria responsible for the creation of thousands of fruits and vegetables as we know them today, with the goal of seeing how ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The big banks have started off the new earnings-reporting ...

Krystal Biotech (NASDAQ:KRYS) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

The Gene Technology Bill continues to make its way through Parliament following feedback from the Health Select Committee.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

A rebound in global biotech deals is set to accelerate as big pharmaceutical companies seek new sources of revenue, according to the International Biotechnology Trust Plc. The pace of dealmaking has ...